Apellis Pharmaceuticals, Inc. (APLS) - Insider Holders & Insider Ownership

List of insiders holdings for Apellis Pharmaceuticals, Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Morningside Venture Investments Ltd
10% Owner		2022-02-14 16:05:1112,806,342
0		12,806,342Form 13G
2Potentia Holdings LLC
10% Owner		2018-02-07 18:59:553,826,601
0		3,826,601Form 13G
3Cormorant Asset Management LLC
Cormorant Global Healthcare Master Fund LP
CORMORANT PRIVATE HEALTHCARE FUND I LP
Chen Bihua
10% Owner		2020-02-14 16:07:262,700,000
0		2,700,000Form 13G
4Cormorant Asset Management LLC
Chen Bihua
Cormorant Global Healthcare GP LLC
Cormorant Global Healthcare Master Fund LP
10% Owner		2020-02-14 16:07:262,700,000
0		2,700,000Form 13G
5AJU IB Investment Co. Ltd.
10% Owner		2017-11-13 16:29:470
2,292,062		2,292,062Form 4
6Hillhouse Capital Management Ltd.
10% Owner		2019-02-14 15:15:042,098,581
0		2,098,581Form 13G
7venBio Global Strategic Fund II L.P.
10% Owner		2019-02-14 08:50:471,790,102
0		1,790,102Form 13G
8GELLERT MICHAEL E
10% Owner		2017-11-13 16:25:54943,989
0		943,989Form 4
9Axon Steven
Chief Business Officer		2018-11-15 20:40:03398,499
0		398,499Form 4
10SCHEIBLER LUKAS
Chief Research Officer		2023-12-05 19:40:46107,690
0		107,690Form 4
11Grossi Federico
Chief Medical Officer		2023-01-09 19:02:3694,884
0		94,884Form 4
12Townsend Adam J.
Chief Commercial Officer		2025-01-30 12:18:2284,050
0		84,050Form 4
13Lewis Karen
Chief People Officer		2025-01-30 12:12:0370,251
0		70,251Form 4
14Eisele Jeffrey
Chief Development Officer		2025-01-30 12:10:4355,312
0		55,312Form 4
15Celona Lucia
See Remarks		2020-02-12 16:58:2636,488
0		36,488Form 4
16Lackner Thomas A.
See Remarks		2020-02-12 16:50:3524,075
0		24,075Form 4
17Brown Victoria L.
Program Team Lead		2023-01-24 16:57:3223,556
0		23,556Form 4
18Sadr Ahmad
See Remarks		2020-02-12 16:46:3019,075
0		19,075Form 4
19Perry Nicole D
Vice President - Accounting		2021-08-03 16:23:5911,008
0		11,008Form 4
20Dunlop A. Sinclair
Director		2026-05-14 19:37:020
0		0Form 4
21Chopas James George
VP/Chief Accounting Officer		2026-05-14 19:34:450
0		0Form 4
22Dolsten Mikael
Director		2026-05-14 19:34:040
0		0Form 4
23MELTZER LESLIE
Chief Research and Development		2026-05-14 19:32:360
0		0Form 4
24FONTEYNE PAUL R.
Director		2026-05-14 19:31:480
0		0Form 4
25Sullivan Timothy Eugene
Chief Financial Officer		2026-05-14 19:30:120
0		0Form 4
26Machiels Alec
Director		2026-05-14 19:29:040
0		0Form 4
27Deschatelets Pascal
Chief Scientific Officer		2026-05-14 19:27:580
0		0Form 4
28Chan Gerald
Director		2026-05-14 19:26:320
0		0Form 4
29Nicholson Nur
Chief Technical Officer		2026-05-14 19:25:380
0		0Form 4
30Walbert Keli
Director		2026-05-14 19:24:070
0		0Form 4
31DeLong Mark Jeffrey
Chief Business & Strat Officer		2026-05-14 19:23:040
0		0Form 4
32O'Brien Stephanie Monaghan
Director		2026-05-14 19:22:010
0		0Form 4
33Boucher Kelley
Chief People Officer		2026-05-14 19:20:570
0		0Form 4
34WHEELER CRAIG A
Director		2026-05-14 19:19:470
0		0Form 4
35Watson David O.
General Counsel		2026-05-14 19:19:050
0		0Form 4
36Francois Cedric
Chief Executive Officer		2026-05-14 19:17:350
0		0Form 4
37Baumal Caroline
Chief Medical Officer		2026-05-14 19:16:010
0		0Form 4
38BIOGEN INC.
See footnotes		2026-05-14 16:36:060
0		0Form 13D